This episode explores women, leadership, and the future of HPB surgery — and we’re joined by someone at the very heart of that conversation: Dr Isabella Frigerio, leading pancreatic surgeon from Italy and President‑Elect of the E‑AHPBA.Together, we delve into the challenges and opportunities for women in HPB, and move beyond gender to discuss mentorship, the qualities that define exceptional surgical leaders, and how we create meaningful opportunities for the next generation. Guest Bio: Dr

Bringing a healthcare innovation to market takes more than a great idea. It takes navigating a complex and constantly changing regulatory landscape. On this episode of the Medical Alley Podcast, we sit down with Mark Gardner, Nate Downing, and Amanda Johnston from Gardner Law to discuss the FDA and CMS issues facing medical technology and healthcare companies. This conversation explores CMS’s Rapid program and changes to NTAP, FDA leadership and review priorities, and how AI may shape regulat...

Many people regularly ask for a strong presentation of my core messages without other bull$hit. So I tried to do that with this one. It’s an attempt. I make attempts like this often. Every one is like opening old wounds and poking old scars. But teaching a new biology 101 is impossible without building a new History of Biology from which to advance. I believe an accurate account of what happened during the pandemic is required to edify the quest for a new History of Biology 101. I am the

If you’re reading this, you probably like plants! Well, you’re not alone – people have been bringing plants into their homes for ages. In this episode, Aly takes us through a brief history of plant parenting!Support us on Patreon: https://www.patreon.com/leafittouspod Connect with us: https://linktr.ee/leafittouspod Our theme song is “Late Bloomer” by Devours. Find more from Devours at https://devours.bandcamp.com/

This is a free preview of a paid episode. To hear more, visit www.razibkhan.comToday Razib talks to Jerry Z. Muller, a historian and professor emeritus of history at the Catholic University of America in Washington, D.C., specializing in modern European intellectual history, capitalism, conservatism, and German and Jewish history. His work explores how ideas shape economic, political, and cultural life, bridging history, philosophy, and public policy. His books include Conservatism: An Anthology of

Type 6s scan for risk, seek security, and often stay locked in a cycle of worst-case thinking — but growth happens when they borrow from their resource point. This week Zach and Laura explore what it looks like when a 6 taps into Type 9 (releasing anxious vigilance, trusting the process, and finding calm, steady peace instead of constant worry).See omnystudio.com/listener for privacy information.

Technology transfer offices usually keep score with patents, licenses, startups and revenue. It's real proof research is moving beyond the lab. Yet it can miss some of the most interesting parts of the story. A technology might reshape clinical practice, influence public policy or strengthen a community without ever producing a commercial outcome that fits neatly into an annual report. As tech transfer evolves, there's a growing opportunity to look past the traditional scorecard and ask how

In this episode of Advancing Health Care Through Simulation, host Lisa George welcomes Jocelyn Rempel, Chair in Older Adult Health at Mount Royal University, Founding Director of the Centre for Health and Innovation in Aging, gerontology nurse, educator and researcher, and co-founder of Rise Care, a health innovation company dedicated to improving care for older adults.Jocelyn shares how education, simulation, virtual care and emerging health technologies are helping older adults maintain

What does personalised medicine actually feel like when you’re the person living with a rare disease?In this episode of When the Code Speaks, we step away from the science and systems of genomic medicine and into the lived experiences of Marc Bulman and Kate Olivier, two UCT students navigating their own health journeys. We talk about diagnosis, uncertainty, searching for answers, navigating healthcare and the ways patients and families often have to become researchers, advocates and educators

In this classic episode of Stuff to Blow Your Mind, Robert and Joe discuss the psychological, economic and decision theory phenomenon known as ambiguity aversion. Find out how it relates to the Ellsberg paradox, madman theory and the balance of power in our world. (orignally published 8/26/2025)See omnystudio.com/listener for privacy information.

Send us Fan Mail After years of running a school on the rigid rhythm of bells, Dr. John Murphy walked away from K-12 education and into something he never trained for: performing history at bars. In this episode, John unpacks how a credentialed academic builds an audience outside the walls of a traditional institution, why humor and analogies are the secret weapons of great storytelling, and what it actually takes to turn expertise into something people will pay a bar tab to hear. Quick note:...

We love to hear from our listeners. Send us a message. In episode 138 of Cell & Gene: The Podcast, EA Weeks, J.D., Ph.D., Counsel at Troutman Pepper Locke talks to Host Erin Harris about the deal terms that matter most in CGT, including IP ownership, manufacturing capacity, CMC milestones, data rights, tech transfer, and more. They also discuss planning for what happens when a partnership does not go as expected. Subscribe to the podcast! Apple | Spotify | YouTube Visit ...

In this Huberman Lab Essentials episode, I revisit episode 2 of my six-part guest series with Dr. Andy Galpin, PhD, an exercise scientist and expert in human performance. We discuss how strength and muscle growth (hypertrophy) differ and why resistance training is important for maintaining physical function as we age. We also explain how to build effective training programs using progressive overload, exercise selection, repetition speed and weekly training volume. Dr. Galpin shares practical tools

Send us Fan Mail In this episode of the Life Science Success Podcast my guest is Chris Sarlo. Chris is the founder of Life Science Wealth, a wealth management practice built exclusively for people inside the life science industry, and the author of The Wealth Gap, a book about why success in science so often fails to turn into lasting wealth. He earned a Bachelor of Commerce from McMaster University, became an accredited financial advisor by twenty-four, and has spent his career working with ...

Michael speaks with Tamar Haspel, The Washington Post's Unearthed columnist and author of To Boldly Grow, about her case for why we should stop eating lettuce. Starting with the explosive diarrhea story behind her column, they examine lettuce's food-safety risks, the healthy reputation of salads, and how to eat well when nutrition advice conflicts. They discuss:(00:00) Preview(00:52) Lettuce and foodborne illness(05:11) Lettuce, water and food waste(09:07) The salad health halo(12:39) Lettuce

In this episode we speak with Rob Klose, Professor of Genetics at the University of Oxford, about how CpG islands help control gene expression and chromatin regulation during development.We discuss how his lab connected CpG islands to histone modifications and chromatin regulation. He describes how KDM2A and KDM2B were found to recognize CpG islands, how this led to the study of H3K36 methylation at promoters, and how BioCAP was developed to isolate non-methylated DNA. He also explains how this

In this episode, host Mary welcomes Christine Ruf, a holistic beauty practitioner with nearly three decades of experience, to explore a different way of looking at menopause—not simply as a collection of symptoms to manage, but as an opportunity for transformation, self-discovery, and rebirth. Christine shares her journey from working in beauty and skincare to exploring Ayurveda, Huna Healing, Spagyric remedies, energy work, emotional balance, facial analysis, and RESET jawline work. Her appr...

Artificial intelligence is dramatically transforming the landscape for every part of pharma. One area where AI is both essential to implement and important to get right is pharmacovigilance, the group concerned with monitoring and maintaining patient safety.In today's pharmaphorum podcast, sponsored by IQVIA Safety Solutions, host Jonah Comstock speaks with Updesh Dosanjh, IQVIA commercialisation lead for safety technology, about how and why the role of AI in pharmacovigilance is changing, as

What if building a world-class biotech company didn’t require owning a single piece of manufacturing equipment or even a lab of your own? Most startups obsess over bricks, mortar, and stainless steel. Not Sandra Núñez. She’s challenging the status quo as CEO of Amela Biosciences by running a “virtual plant” model: zero in-house production, everything outsourced, and agility baked into every decision. It’s a bold experiment in redefining what a biotech company can look like. One that’s already...